|
ZNF544 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18939999996337E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.13000000000219E-05 |
| Normal-vs-Stage2 |
2.828500E-02 |
| Normal-vs-Stage3 |
2.217900E-03 |
| Normal-vs-Stage4 |
5.682300E-02 |
| Stage1-vs-Stage2 |
6.291400E-01 |
| Stage1-vs-Stage3 |
1.545780E-01 |
| Stage1-vs-Stage4 |
3.390600E-01 |
| Stage2-vs-Stage3 |
5.850000E-01 |
| Stage2-vs-Stage4 |
6.662600E-01 |
| Stage3-vs-Stage4 |
9.986000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.63280000040767E-07 |
| Normal-vs-AfricanAmerican |
2.097800E-02 |
| Normal-vs-Asian |
8.775400E-01 |
| Caucasian-vs-AfricanAmerican |
2.674800E-01 |
| Caucasian-vs-Asian |
2.566400E-01 |
| AfricanAmerican-vs-Asian |
4.945000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.76709999989112E-07 |
| Normal-vs-Female |
1.346410E-02 |
| Male-vs-Female |
2.793400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.695700E-02 |
| Normal-vs-Extreme_Weight |
6.7551000004773E-07 |
| Normal-vs-Obese |
9.136000E-03 |
| Normal-vs-Extreme_Obese |
4.853700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.735000E-01 |
| Normal_Weight-vs-Obese |
8.791800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.247600E-01 |
| Extreme_Weight-vs-Obese |
1.591440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.722600E-01 |
| Obese-vs-Extreme_Obese |
2.588600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.934000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.878500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.49599999998973E-06 |
| Normal-vs-Age(81-100Yrs) |
6.614100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.045600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.880590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.102300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.007360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.278000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.112560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.826800E-04 |
| Normal-VS-Type2 PRCC |
7.80409999956433E-07 |
| Normal-VS-KIRP CIMP |
4.252400E-01 |
| Normal-VS-Unclassified PRCC |
1.418090E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.316300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.535200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.833570E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.766770E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.682400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.629800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77510000000303E-05 |
| Normal-vs-N1 |
1.058420E-01 |
| Normal-vs-N2 |
4.4503999996337E-07 |
| N0-vs-N1 |
2.530800E-01 |
| N0-vs-N2 |
1.468550E-01 |
| N1-vs-N2 |
8.719700E-02 |
|
|
